181 related articles for article (PubMed ID: 33881805)
21. Synthesis and characterization of the monomer ruthenium complex of hypocrellin B.
Zhou J; Liu J; Feng Y; Wei S; Gu X; Wang X; Zhang B
Bioorg Med Chem Lett; 2005 Jun; 15(12):3067-70. PubMed ID: 15913997
[TBL] [Abstract][Full Text] [Related]
22. Internal heavy atom effect of Au(III) and Pt(IV) on hypocrellin A for enhanced in vitro photodynamic therapy of cancer.
Zhou L; Ge X; Liu J; Zhou J; Wei S; Li F; Shen J
Bioorg Med Chem Lett; 2013 Oct; 23(19):5317-24. PubMed ID: 23978649
[TBL] [Abstract][Full Text] [Related]
23. Cytoprotective role of nitric oxide in HepG2 cell apoptosis induced by hypocrellin B photodynamic treatment.
Ji YY; Ma YJ; Wang JW
J Photochem Photobiol B; 2016 Oct; 163():366-73. PubMed ID: 27619738
[TBL] [Abstract][Full Text] [Related]
24. Effect of structural modifications on photosensitizing activities of hypocrellin dyes: EPR and spectrophotometric studies.
Yuying H; Jingyi A; Lijin J
Free Radic Biol Med; 1999 May; 26(9-10):1146-57. PubMed ID: 10381185
[TBL] [Abstract][Full Text] [Related]
25. Zeolitic Imidazolate Framework Platform for Combinational Starvation Therapy and Oxygen Self-Sufficient Photodynamic Therapy against a Hypoxia Tumor.
Ouyang Y; Wang P; Huang B; Yang G; Tian J; Zhang W
ACS Appl Bio Mater; 2021 May; 4(5):4413-4421. PubMed ID: 35006853
[TBL] [Abstract][Full Text] [Related]
26. Gelatin nanocarrier enables efficient delivery and phototoxicity of hypocrellin B against a mice tumour model.
Babu A; Jeyasubramanian K; Gunasekaran P; Murugesan R
J Biomed Nanotechnol; 2012 Feb; 8(1):43-56. PubMed ID: 22515093
[TBL] [Abstract][Full Text] [Related]
27. Selective Photodynamic Effects on Breast Cancer Cells Provided by p123 Pluronic®- Based Nanoparticles Modulating Hypericin Delivery.
Damke GMZF; Souza RP; Montanha MC; Damke E; Gonçalves RS; César GB; Kimura E; Caetano W; Hioka N; Consolaro MEL
Anticancer Agents Med Chem; 2020; 20(11):1352-1367. PubMed ID: 30387402
[TBL] [Abstract][Full Text] [Related]
28. Hypocrellin B-encapsulated nanoparticle-mediated rev-caspase-3 gene transfection and photodynamic therapy on tumor cells.
Bai D; Xia X; Yow CM; Chu ES; Xu C
Eur J Pharmacol; 2011 Jan; 650(2-3):496-500. PubMed ID: 20970418
[TBL] [Abstract][Full Text] [Related]
29. Ionic liquid induced highly dense assembly of porphyrin in MOF nanosheets for photodynamic therapy.
Qin JH; Zhang H; Sun P; Huang YD; Shen Q; Yang XG; Ma LF
Dalton Trans; 2020 Dec; 49(48):17772-17778. PubMed ID: 33245085
[TBL] [Abstract][Full Text] [Related]
30. Enhanced Photodynamic Therapy by Reduced Levels of Intracellular Glutathione Obtained By Employing a Nano-MOF with Cu
Zhang W; Lu J; Gao X; Li P; Zhang W; Ma Y; Wang H; Tang B
Angew Chem Int Ed Engl; 2018 Apr; 57(18):4891-4896. PubMed ID: 29451722
[TBL] [Abstract][Full Text] [Related]
31. Nd
Liu C; Liu B; Zhao J; Di Z; Chen D; Gu Z; Li L; Zhao Y
Angew Chem Int Ed Engl; 2020 Feb; 59(7):2634-2638. PubMed ID: 31750975
[TBL] [Abstract][Full Text] [Related]
32. Effect of photodynamic therapy with hypocrellin B on apoptosis, adhesion, and migration of cancer cells.
Jiang Y; Leung AW; Wang X; Zhang H; Xu C
Int J Radiat Biol; 2014 Jul; 90(7):575-9. PubMed ID: 24661233
[TBL] [Abstract][Full Text] [Related]
33. Polyethylene glycol-modified gelatin/polylactic acid nanoparticles for enhanced photodynamic efficacy of a hypocrellin derivative in vitro.
Babu A; Periasamy J; Gunasekaran A; Kumaresan G; Naicker S; Gunasekaran P; Murugesan R
J Biomed Nanotechnol; 2013 Feb; 9(2):177-92. PubMed ID: 23627044
[TBL] [Abstract][Full Text] [Related]
34. 808 nm Light-triggered and hyaluronic acid-targeted dual-photosensitizers nanoplatform by fully utilizing Nd(3+)-sensitized upconversion emission with enhanced anti-tumor efficacy.
Hou Z; Deng K; Li C; Deng X; Lian H; Cheng Z; Jin D; Lin J
Biomaterials; 2016 Sep; 101():32-46. PubMed ID: 27267626
[TBL] [Abstract][Full Text] [Related]
35. Synergistically enhanced multienzyme catalytic nanoconjugates for efficient cancer therapy.
Yin SY; Liu W; Yang J; Li J
J Mater Chem B; 2021 Jul; 9(29):5877-5886. PubMed ID: 34259273
[TBL] [Abstract][Full Text] [Related]
36. Photodynamic-induced vascular damage of the chick chorioallantoic membrane model using perylenequinones.
Chin W; Lau W; Lay SL; Wei KK; Olivo M
Int J Oncol; 2004 Oct; 25(4):887-91. PubMed ID: 15375536
[TBL] [Abstract][Full Text] [Related]
37. Photosensitization with anticancer agents. 18. Perylenequinonoid pigments as potential photodynamic therapeutic agents: preparation and photodynamic properties of amino-substituted hypocrellin derivatives.
Diwu Z; Zhang C; Lown JW
Anticancer Drug Des; 1993 Apr; 8(2):129-43. PubMed ID: 8494603
[TBL] [Abstract][Full Text] [Related]
38. A new near infrared photosensitizing nanoplatform containing blue-emitting up-conversion nanoparticles and hypocrellin A for photodynamic therapy of cancer cells.
Jin S; Zhou L; Gu Z; Tian G; Yan L; Ren W; Yin W; Liu X; Zhang X; Hu Z; Zhao Y
Nanoscale; 2013 Dec; 5(23):11910-8. PubMed ID: 24129918
[TBL] [Abstract][Full Text] [Related]
39. Synthesis of Au@MOF core-shell hybrids for enhanced photodynamic/photothermal therapy.
Cai X; Zhao Y; Wang L; Hu M; Wu Z; Liu L; Zhu W; Pei R
J Mater Chem B; 2021 Sep; 9(33):6646-6657. PubMed ID: 34369551
[TBL] [Abstract][Full Text] [Related]
40. Hypocrellin B enhances ultrasound-induced cell death of nasopharyngeal carcinoma cells.
Wang P; Xu CS; Xu J; Wang X; Leung AW
Ultrasound Med Biol; 2010 Feb; 36(2):336-42. PubMed ID: 20018428
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
